Xeltis Raises €32M to Develop Restorative Cardiac Devices miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Xeltis raises €32 million to drive clinical development of world's most advanced restorative cardiovascular devices New investors DaVita Venture Group and Invest-NL join syndicate of international
/PRNewswire/ Today, DaVita recognizes the impact its employees, known as teammates, had on kidney care in 2022. Over the last year, DaVita made strides in.
Add an Ask the Investor breakfast meeting to your INVEST Digital Health agenda and gain insights from investors from DaVita Venture Group, Noro-Moseley Partners, Providence Ventures, FirstTrust Capital, Blue Cross Blue Shield Kansas, and Flare Capital Partners.